全球神經復健設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計神經復健設備市場規模將從 2025 年的 27.4 億美元成長到 2034 年的 91.8 億美元，2026 年至 2034 年的複合年成長率為 14.36%。

由於中風、脊髓損傷和神經退化性疾病的發生率不斷上升，神經復健設備市場正經歷顯著成長。急診醫學的進步提高了患者的生存率，從而推動了對長期康復解決方案的需求成長。機器人技術、穿戴式裝置和腦刺激系統等領域的技術創新正在改變傳統的治療方法。醫療機構正在擴大設備輔助復健的應用範圍，以改善復健效果並增強患者的活動能力。

人口老化和人們對早期康復益處的認知不斷提高是成長要素。機器人輔助治療和虛擬實境（VR）系統能夠實現重複性、可控的運動，從而促進神經功能恢復。醫療保健支出不斷成長以及政府支持復健基礎設施的政策也是推動成長的因素。此外，遠距復健解決方案正在擴大偏遠地區和醫療資源匱乏地區獲得治療服務的機會。

展望未來，將人工智慧 (AI) 和數據分析融入復健設備有望提升治療方案的個人化和效率。隨著經濟實惠的穿戴式技術日益普及，市場預計將持續成長。專注於檢驗臨床療效和以患者為中心的設計理念的公司將在塑造神經復健護理的未來方面發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球神經復健設備市場：依產品分類

• 市場分析、洞察與預測
• 神經機器人學
• 腦機介面
• 穿戴式裝置
• 非侵入性刺激器
• 其他

第5章 全球神經復健設備市場：依治療領域分類

• 市場分析、洞察與預測
• 中風
• 帕金森氏症
• 多發性硬化症
• 腦性麻痹
• 其他

第6章 全球神經復健設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bioventus
  • Ectron
  • Hocoma
  • Medtronic
  • Tyromotion Inc
  • Biometrics Ltd
  • Bionik Laboratories Corp.（BNKL）
  • BioXtreme Ltd
  • Ekso Bionics
  • Kinestica
  • Kinova Inc
  • Saebo Inc
  • Abbott

The Neurorehabilitation Devices Market size is expected to reach USD 9.18 Billion in 2034 from USD 2.74 Billion (2025) growing at a CAGR of 14.36% during 2026-2034.

The neurorehabilitation devices market is witnessing significant growth due to the rising prevalence of stroke, spinal cord injuries, and neurodegenerative disorders. Improvements in emergency care have increased survival rates, creating greater demand for long-term rehabilitation solutions. Technological advancements in robotics, wearable devices, and brain stimulation systems are transforming traditional therapy methods. Healthcare providers are increasingly adopting device-assisted rehabilitation to enhance recovery outcomes and improve patient mobility.

Key drivers include the growing elderly population and increased awareness about early rehabilitation benefits. Robotic-assisted therapy and virtual reality-based systems allow repetitive, controlled movements that improve neurological recovery. Rising healthcare expenditure and government initiatives supporting rehabilitation infrastructure are also fueling growth. Additionally, tele-rehabilitation solutions are expanding access to therapy services in remote and underserved regions.

Looking forward, integration of artificial intelligence and data analytics into rehabilitation devices is expected to personalize therapy programs and improve efficiency. The market will likely expand as cost-effective wearable technologies become more accessible. Companies focusing on clinical validation and patient-centric designs will play a critical role in shaping the future of neurorehabilitation care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Neurorobotics
• Brain-Computer Interface
• Wearable Devices
• Non-Invasive Stimulators
• Others

By Therapy Area

• Stroke
• Parkinson's Disease
• Multiple Sclerosis
• Cerebral Palsy
• Others

COMPANIES PROFILED

• Bioventus, Ectron, Hocoma, Medtronic, Tyromotion Inc, Biometrics Ltd, Bionik Laboratories Corp BNKL, BioXtreme Ltd, Ekso Bionics, Kinestica, Kinova Inc, Saebo Inc, Abbott
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Neurorobotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Brain-Computer Interface Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Non-Invasive Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY THERAPY AREA 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy Area
• 5.2. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parkinson's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Multiple Sclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cerebral Palsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Therapy Area
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Therapy Area
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Therapy Area
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Therapy Area
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Therapy Area
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEUROREHABILITATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Bioventus
  • 8.2.2 Ectron
  • 8.2.3 Hocoma
  • 8.2.4 Medtronic
  • 8.2.5 Tyromotion Inc
  • 8.2.6 Biometrics Ltd
  • 8.2.7 Bionik Laboratories Corp. (BNKL)
  • 8.2.8 BioXtreme Ltd
  • 8.2.9 Ekso Bionics
  • 8.2.10 Kinestica
  • 8.2.11 Kinova Inc
  • 8.2.12 Saebo Inc
  • 8.2.13 Abbott